Directory · CA
Biotechnology in Canada
A register of firms and the professionals working at them in the Biotechnology sector based in Canada. Browse the public index, then filter or export on Kipplo.
Companies
245 on file
Biovectra
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Biologics Synthetic small molecules Fermented small molecules Highly potent APIs Bioreagents mRNA, pDNA, LNP manufacturing Fill/Finish Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
501 to 1000 staff
Acadian Seaplants
Acadian Seaplants is a seaweed and food-supply chain company that provides plants, animals and people with sustainable sources of essential nutrients and organic compounds. We began as a family-owned seaweed company nestled in the heart of Atlantic Canada. Our vision, our passionate people and an incredible renewable resource carried us onto the global stage. Now, we offer sustainable, high-quality and research-based solutions in over 80 countries that satisfy the vital needs of plants, animals and people.
201 to 500 staff
Canam Bioresearch Inc
CanAm Bioresearch is a well-established North American based medicinal chemistry Contract Research Organization (CRO) with more than 20 years of experience in drug discovery. We have a long history working with start-ups and spin-outs worldwide and providing discounts and flexible payment arrangements during the pre-seed and seed funding stages of the company life cycle. Our team excels in medicinal chemistry, custom chemical synthesis and analytical services. Our highly skilled team of organic and medicinal PhD chemists have the knowledge and experience to resolve various challenges, delivering high quality results in a timely manner. We specialize in synthetic organic chemistry to support SAR of drug discovery programs at the hit-to-lead and lead optimization stages, including scale-up batches to enable early toxicology studies. We also offer chemical library synthesis, custom organic synthesis, and analytical services (including HPLC-UV and LC-MS analysis, purity analysis and process monitoring, stability and solubility determinations). Additionally, we can manage fully integrated pre-clinical ADME/PK profiling assays. Our research facility is fully equipped with all the instruments for efficient organic synthesis and analysis (including microwave reactors, automated purification systems, multinuclear NMR, mass spectrometers, analytical and semi-preparative HPLCs, and LC-MS/MS units dedicated to ADME analysis). Each chemist involved in your project is a PhD skilled in the art of medicinal chemistry and organic synthesis and presents progress reports directly to you at regular meetings. The chemists working at the bench on your project are always accessible to you and act as your in-house research team.
11 to 50 staff
K' Prime Technologies Inc
K′(Prime) Technologies Inc. or K′(Prime) is a global imaging services company headquartered in Calgary, Alberta, and wholly owned by Nanalysis Scientific Corp.(TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1). K′(Prime)’s capabilities encompass chemistry, commercial security, sales of scientific instruments, and airport imaging services, including X-ray and millimetre wave imaging. K'(Prime)'s mission is to redefine imaging security across Canada and the world through continuous innovation, data-driven insights, and trusted partnerships—empowering safer, smarter environments for tomorrow. Our vision is to lead Canada in imaging security innovation—delivering expertise globally in installation, consultation, maintenance, sales, and optimization of advanced systems that protect people, assets, and infrastructure with intelligence and reliability. K'(Prime) is Canada’s Imaging Security Leader—Delivering What Others Can’t 1. Nationwide Responsiveness Coast-to-coast coverage—ready to respond within hours, where others can’t. Cross-Functional Expertise Situation-ready teams with deep technical and operational knowledge to solve complex challenges and ensure regulatory compliance. Strategic Parts Availability A robust distribution network ensures minimal downtime—clients stay operational, even under pressure. Dependability When It Matters Most The trusted choice when others fall short—clients call us when they’ve been left stranded. Customer-Centric Performance We protect our clients’ bottom line. Their success is our success—driven by up-time, reliability, and peace of mind.
51 to 200 staff
Nod Apiary Products Ltd
NOD Apiary Products Ltd. is a Canadian company formed in 1997 by beekeepers in Canada. Honeybee and animal health is our focus. The founders at NOD saw formic acid as the active ingredient most likely to be developed into a practical, sustainable miticide for the beekeeping industry. Properly formulated, it could control varroa, tracheal and tropilaelaps mites, protect the image of honey as a wholesome food, and leave no residues in the hive components. NOD Apiary Products Ltd. continues to aid the developing apiculture industry by producing organic and sustainable Honey bee health products. Formic Pro™ and the Mite Away Quick Strips (MAQS Beehive Strips) are formic acid polysaccharide gel strips which, when placed in the brood chamber of a honey bee hive, act as an organic miticide that kills the varroa mite where it reproduces, under the brood cap. The Formic Pro™ and MAQS™ technology eliminates the risk of residues; beekeepers can use it safely during the honey flow. Formic Pro™ and Mite Away Quick Strips (MAQS Beehive Strips) are registered in several countries across Europe, and in Canada, The United States, and New Zealand. NOD Apiary Products’ Bee Cozy Winter Hive Wraps have been used successfully in the field for over 25 years. By properly preparing Honey bees for winter, colonies consume less feed stores and reach maximum health and vigour earlier in the season. Easy to work with, the Bee Cozy ‘slip-on, slip-off’ system saves beekeepers valuable time getting ready for winter. NOD Apiary Products’ focus on honey bee health expanded when the dairy farmers on our team discovered that organic acids, like formic acid, could also be used for livestock. The Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) research on Acidified Milk Feeding Programs for the dairy cow, goat and sheep industries inspired NOD employees to investigate. The results were very positive and we launched the newest addition to our product line, Nature’s Way 9.8™.
11 to 50 staff
Biodextris
Follow us for the latest on our expansion, job opportunities and the latest relevant news in our space! Biodextris is comprised of experienced product development scientist located in Laval (Montreal), Quebec. The group has worked together since 2002, as part of ID Biomedical and later GSK-Vaccines. We have developed numerous products for all phases of clinical development for programs conducted in the US, Canada and Europe. Companies choose to work with us because we are experts in developing complete analytical packages for novel and complex products. Companies trust us to accelerate their project from the bench to the clinic by delivering robust and reliable production processes ready for manufacturing. Companies rely on our Quality Control testing services for their clinical phase vaccines and biologics. We look forward to sharing this expertise with you.
11 to 50 staff
Ceapro
Ceapro Inc. is a Canadian biotechnology company involved in the development and commercialization of “active ingredients” derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. Ceapro’s patented process technologies include its Pressurized Gas eXpanded (PGX) technology which is a unique and disruptive technology with several key advantages over conventional drying and purification methods that can be used to process biopolymers into high-value, nano-sized polymer structures and novel bio-nanocomposites. Ceapro also utilizes its proprietary plant extraction-based manufacturing process to supply ingredients to well-known personal care and cosmetic industries worldwide. The Company’s two value-driving products, oat beta glucan and avenanthramides, are found in many household names, cosmetic and personal care brands. These products are manufactured from Ceapro’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Oat beta glucan effectively stimulates collagen synthesis and deeply moisturizes the skin (epidermis and dermis) thereby improving skin restructuring, decreasing wrinkles and allowing wound healing with minimal scaring. When taken orally, oat beta glucan has been shown to improve cholesterol levels and therefore has “heart health” approved health claims in Canada, United States and Europe. Avenanthramides are polyphenolic compounds found exclusively in oats which act as natural anti-oxidant, anti-irritant and anti-inflammatory. When added to topical formulation, avenanthramides effectively reduce redness and itchiness due to inflammation. In oral formulations, avenanthramides could treat serious conditions triggered by inflammation. Given the therapeutic benefits of the Company’s two flagship products, Ceapro is currently expanding and developing them for use in the nutraceutical industries.
11 to 50 staff
Nicoya
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, is capable of accelerating drug discovery using a fraction of sample volume traditionally required for biomolecular interaction analyses. Alto helps biotechnology and pharmaceutical companies go-to-market faster with increased efficiency and success early in their product pipelines. Join us on our mission to improve human life by helping scientists to succeed. For job opportunities, see our webpage at https://nicoyalife.com/about/careers/
51 to 200 staff
Sernova
Sernova (TSX: SVA)(OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing its implantable Cell Pouch™ bio-hybrid organ which works to restore the body’s normal function so that people with type 1 diabetes (T1D) and other chronic diseases can focus on what matters most: living their lives.
11 to 50 staff
Biena
We are a Canadian company specializing in the production of probiotic strains, starters, and ripening cultures. Our mission is to collaborate with you to develop innovative and effective solutions that meet your growth objectives. Our m² state-of-the-art cGMP production facility houses all of our departments, allowing us to create outstanding products that meet FDA, Halal, Non-GMO Project Verified, ID Verified, and cGMP certifications. Nous sommes une entreprise canadienne spécialisée dans la production de souches probiotiques et de ferments d’acidification & d’affinage. Notre mission est de collaborer avec vous pour développer des solutions innovatrices et efficaces qui répondent à vos objectifs de croissance. Nos m² d'installations cGMP à la fine pointe de la technologie, regroupent tous nos départements afin de créer des produits exceptionnels qui répondent aux certifications FDA, Halal, Non-GMO Project Verified, ID Verified, et cGMP.
51 to 200 staff
Custom Biologics
Custom Biologics is a regulatory compliant large molecule bioanalytical CRO specializing in the potency assessment and clinical testing of biologic-based drugs, vaccine, and gene therapy products. Our scientists and quality assurance team provides exceptional, high quality, customized assays to measure the functional properties of cellular and biotherapeutic drug candidates. We are a Health Canada audited, GMP-compliant, global service provider for functional testing of biotherapeutics, biosimilars and antibody drug conjugates. For nearly 20 years, our scientists have been designing and validating sophisticated bioanalytical assays to characterize and measure the therapeutic potential of large and small molecule biotherapeutics. Our work supports regulatory drug submission applications from biopharmaceutical companies throughout North America, Europe and Asia. Great Science - It's at the heart of everything we do!
11 to 50 staff
Geneseeq Technology Inc
Geneseeq Technology Inc. is a research-driven global leader in precision oncology, advancing cancer detection, diagnosis, and treatment through cutting-edge next-generation sequencing (NGS) technologies. With headquarters in Canada and China, Geneseeq operates CAP, CLIA, and ISO 15189-accredited laboratories for central laboratory testing, and is ISO 13485-certified for the development and manufacturing of both in vitro diagnostic (IVD) and research use only (RUO) testing kits. Our comprehensive testing portfolio includes-Pan-cancer panels covering over 400 genes-Cancer-type-specific panels tailored for solid tumors and hematologic malignancies-Minimal residual disease (MRD) monitoring technologies-Multi-cancer early detection (MCED) solutions, including CanScan®, which holds both CE mark and FDA Breakthrough Device Designation-CE-IVD and NMPA-approved NGS-based assays, including tumor mutational burden (TMB) testing. Geneseeq’s testing services and products are widely adopted by more than oncologist partners across 20+ countries and regions. We are actively involved in over 2,700 research collaborations with pharmaceutical and academic partners, providing high-quality genomic data to support biomarker discovery, clinical development, and translational research. Driven by innovation and a commitment to quality, Geneseeq delivers integrated NGS solutions that help guide personalized treatment decisions and accelerate the global adoption of precision cancer care.
1001 to 5000 staff
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows us to maintain our leadership position in the space. • Best-in-class LNP + next generation ligand conjugate technologies • First and only FDA-approved siRNA-LNP utilizes Genevant technology • Nucleic acid payload design expertise • Several hundred patents worldwide • LNP technology evaluated in more than a dozen clinical programs, representing hundreds of subjects and patients • An established leader in delivery to the liver, now focusing capabilities on other tissues and cell types • Experienced team with deep technical expertise and a track record of innovation and creative corporate partnering
11 to 50 staff
Mrm Proteomics Inc
MRM Proteomics is at the leading edge of precision proteomics technology. We offer a wide range of proteomics services and easy-to-use kits. We are also involved in developing clinical diagnostics. Our mission is to offer the highest quality of proteomics technologies on the market today. We also offer unique custom-tailored solutions for specific research projects. Our technology advantages include: MRM-MS with paired heavy/light peptide standards for high-precision highly-multiplexed quantitation of hundreds of proteins; Patented iMALDI-MS technology for robust high-throughput clinical proteomics; High-resolution HDX structural characterization of proteins and biosimilars; and Tissue imaging of peptides and lipids using innovative techniques (patent pending)
11 to 50 staff
Northern Rna Inc
We are a Canadian CDMO specializing in the production of nucleic acid products that support life-enabling work. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.
51 to 200 staff
Acuitas Therapeutics
Acuitas is the premier LNP (lipid nanoparticle) technology provider, enabling our partners to advance new therapeutics to address unmet clinical needs. We have developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics. Our mission is · To provide our partners with the best LNP delivery technology for nucleic acid therapeutics · To support our partners to rapidly advance new therapeutics to address unmet medical needs · To continually innovate to maintain and strengthen our LNP technological lead Acuitas partners locally and globally with companies, academic institutes and other organizations to improve human health.
51 to 200 staff
Avivo Biomedical Inc
Avivo, a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. This innovative platform enables a world where a person’s blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions. Avivo’s platform will enable healthcare providers to better prioritize patients by medical urgency, spend less on management and logistics and ultimately save more lives.
1 to 10 staff
Cannapiece Corp
CannaPiece Corp is a global leader in cannabinoid processing and manufacturing, seeking to establish new standards in the global cannabis industry. We have services and products to cover the gaps in the current supply chain, including; R&D, Product Development, Third-Party Processing, Packaging, Large-Scale Extraction, Production of Edibles, Topicals and Concentrates as well as White-Labeled products to both Domestic and International markets. We strive to be one of the most trusted and reliable manufacturing facilities globally.
51 to 200 staff
Itr Laboratories Canada Inc
ITR Canada provides preclinical testing services for the pharmaceutical and biotechnology industries. Since our founding in 1989 we have grown into a mid-sized Contract Research Organization (CRO). As a CRO with extensive experience, we provide you with valuable input and best practices, which ultimately help you maximize the value of your research investment. We deliver on time project reporting that meets your company’s goals. ITR Canada offre des services d’essais précliniques pour les industries pharmaceutiques et de biotechnologie. Depuis notre création en 1989, nous nous sommes développée en une organisation de recherche contractuelle (CRO) de taille moyenne grandissante. En tant que CRO avec une vaste expérience, nous vous fournissons une contribution valable et les meilleures pratiques disponibles, qui vous aident finalement à optimiser la valeur de votre investissement en recherche. Nous vous livrons des rapports de projet en temps voulu et qui répondent aux objectifs de votre entreprise.
201 to 500 staff
Life Sciences Bc
Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
1 to 10 staff
Ubrigene Biosciences Inc
uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.
11 to 50 staff
48hour Discovery
Founded in 2017, 48Hour Discovery (48HD) has a powerful technology platform for peptide-based drug discovery. We are reducing the cost, time, and risk of developing new therapies with our innovative target screening strategy to quickly identify the best and most promising drug leads.
11 to 50 staff
Advanced Electrophoresis Solutions Ltd. Aes
Advanced Electrophoresis Solutions Ltd.(AES) is committed to offering comprehensive solutions in whole-column imaging detection capillary isoelectric focusing (WCID-iCIEF). Specializing in system development, we also provide customized critical reagents tailored to Fusion proteins, Antibody-Drug Conjugates (ADCs), monoclonal antibodies (mAbs), and more. Additionally, AES supplies an extensive range of consumables, ensuring a complete offering for our clients' diverse needs.
11 to 50 staff
Allarta Life Science Inc
A pre-clinical regenerative medicine company building transformative platform technology to deliver cells and stem cells to patients world-wide.
11 to 50 staff
